Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index. Mascarella MA, Mlynarek A, Richardson K, Vendra V, et al. Oral Oncol 2026;176:107943.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mascarella MA, Mlynarek A, Richardson K, Vendra V, et al. Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index. Oral Oncol 2026;176:107943.
PMID: 41905240